Read 'Invest in ME's' Parliamentary Briefing

UK charity Invest in ME has written a briefing for the 21 June Westminster Hall debate that calls for £20 million in funding for biomedical research for five years. The briefing also provides an excellent summary of the disease and the challenges patients face accessing appropriate care.
 
[maxbutton id=”16″ url=”http://investinme.org/Documents/Fact%20Sheets/Status%20of%20Research,%20Treatment%20and%20Perception%20of%20Myalgic%20Encephalomyelitis%202018.pdf” text=”Read the briefing” ]

     

    1. Here is a summary of the briefing’s seven recommendations:

      1. A Public Inquiry into ME based on The Gibson Report,” which states:
        “There have been numerous cases where advisors to the DWP have also had consultancy roles in medical insurance companies. Particularly the Company UNUM Provident. Given the vested interest private medical insurance companies have in ensuring CFS/ME remain classified as a psychosocial illness there is blatant conflict of interest here.”
      2. Implement the CMO Report Recommendations. The recommendations from the CMO Report of 2002 should be implemented.
      3. Removal of Existing NICE Guidelines for ME. As a stop-gap measure NICE can remove CBT and GET as recommendations for ME immediately and issue an addendum to the existing guidelines warning all doctors that CBT and GET must not be recommended for ME.
        NICE must also inform all healthcare providers around the world, who may be using the NICE guidelines for their own healthcare systems, that this addendum has been made.
      4. Annual Report to Parliament
      5. Transparency of Meetings – Full transparency of any meetings between NIHR, MRC, DoH, NHS
      6. Remove Those Responsible for Current Situation.
        All of those individuals who have been connected with MRC decisions on research into ME over the last decade, if still in positions of influence with regard to ME research, must be removed from having any influence on future decisions regarding ME. The people whom the MRC has made responsible have failed. Whether this has been on purpose or not remains to be seen. In any case, they should play no further role in influencing any policies relating to ME.
      7.  Research. Invest in ME Research propose ring-fencing funding of at least £20 million a year for five years for biomedical research into ME.
Facebook
Twitter
WhatsApp
Email

1 thought on “Read 'Invest in ME's' Parliamentary Briefing”

  1. Neurosteroids need replacing in the brain and Thyroid medications of both T3 & T4 or Desiccated Thyroid usually need prescribing as well as pregnenolone.
    Low-Dose Naltrexone should be available for prescription
    Minerals imbalances should be corrected
    Mold, Candida or Heavy Metals should be treated or detoxed
    D-Lactate Acidosis should be treated
    All B Vitamins need supplementing
    Keto Diet or High Fat Diet is a good idea
    Liver Detoxing
    Antioxidants should be used to clear brain fog and Mitochondria support supplements

Comments are closed.

Latest News

reddish rectangle image with different color stripes of red coming out at a diagonal from the center. In the center is the TeachMETreatME logo. The words celebrating an impactful campaign in white font underneath the logo.

#TeachMETreatME: Celebrating An Impactful Campaign

We are THRILLED to share the rolling successes of our #TeachMETreatME campaign with you, as we report back on the amazing medical education events that have taken place so far – with many more to come in the upcoming months! (And don’t miss the global #MillionsMissing events later in the article!) Over the past several

Read More »

#MillionsMissing Week is Here: #TeachMETreatME in Action!

We are excited to announce the kick-off of #MillionsMissing 2024 – our ongoing campaign to Teach ME and Treat ME by educating medical providers across our nation’s hospital systems and medical schools about myalgic encephalomyelitis (ME).  Throughout the spring, summer and fall, #MEAction teams are hosting 13 medical education events to encourage medical providers to

Read More »

#MEAction’s Jaime Seltzer Selected for TIME100 Health 2024

We are thrilled to share with you that Jaime Seltzer, #MEAction’s Scientific Director, has been selected for TIME100 Health 2024, TIME’s new annual list of 100 individuals who most influenced global health this year! This is a huge honor based on years of work fighting for equity for people with ME.  We intimately know the

Read More »
Scroll to Top